BACKGROUND: Nodal staging constitutes an element of great importance in the treatment planning for early breast cancer. The ACOSOG Z0011 trial demonstrated that sentinel lymph node (SLN) biopsy alone results in rates of local control, disease-free survival, and overall survival equivalent to those seen after axillary lymph node dissection. The purpose of this study was to determine the rate of patients that fulfill the ACOSOG Z0011 inclusion criteria and to define predictive factors for non-SLN positivity. METHODS: A retrospective analysis of the breast surgery database of the Argentinian Society of Mastology was carried out. Patients were selected if they fulfilled the ACOSOG Z0011 inclusion criteria. The association of clinical and pathological factors with non-SLN positivity was evaluated in univariate and multivariate analysis. RESULTS: Among 8,262 patients, 973 had positive SLN, and 348 satisfied the inclusion criteria. Histological grade (G3 vs. G1-2, odds ratio (OR) 1.81; p = 0.024), tumor size (T2 vs. T1, OR 2.39; p = 0.001), and age (>50 vs. <50 years, OR 1.95; p = 0.007) were associated with non-SLN positivity in multivariate analysis. CONCLUSION: Although the clinical relevance of our data is not established, older women with tumors bigger than 2 cm and/or high histological grade are at greater risk of having metastatic disease in the lymph nodes if axillary lymph node dissection is avoided. This subgroup of patients represents only 30% of the trial population.
BACKGROUND: Nodal staging constitutes an element of great importance in the treatment planning for early breast cancer. The ACOSOG Z0011 trial demonstrated that sentinel lymph node (SLN) biopsy alone results in rates of local control, disease-free survival, and overall survival equivalent to those seen after axillary lymph node dissection. The purpose of this study was to determine the rate of patients that fulfill the ACOSOG Z0011 inclusion criteria and to define predictive factors for non-SLN positivity. METHODS: A retrospective analysis of the breast surgery database of the Argentinian Society of Mastology was carried out. Patients were selected if they fulfilled the ACOSOG Z0011 inclusion criteria. The association of clinical and pathological factors with non-SLN positivity was evaluated in univariate and multivariate analysis. RESULTS: Among 8,262 patients, 973 had positive SLN, and 348 satisfied the inclusion criteria. Histological grade (G3 vs. G1-2, odds ratio (OR) 1.81; p = 0.024), tumor size (T2 vs. T1, OR 2.39; p = 0.001), and age (>50 vs. <50 years, OR 1.95; p = 0.007) were associated with non-SLN positivity in multivariate analysis. CONCLUSION: Although the clinical relevance of our data is not established, older women with tumors bigger than 2 cm and/or high histological grade are at greater risk of having metastatic disease in the lymph nodes if axillary lymph node dissection is avoided. This subgroup of patients represents only 30% of the trial population.
Entities:
Keywords:
Breast cancer; Lymphatic metastasis; Sentinel lymph node biopsy
Authors: M A den Bakker; A van Weeszenberg; A Y de Kanter; F H Beverdam; C Pritchard; Th H van der Kwast; M Menke-Pluymers Journal: J Clin Pathol Date: 2002-12 Impact factor: 3.411
Authors: Giuseppe Viale; Stefano Zurrida; Eugenio Maiorano; Giovanni Mazzarol; Giancarlo Pruneri; Giovanni Paganelli; Patrick Maisonneuve; Umberto Veronesi Journal: Cancer Date: 2005-02-01 Impact factor: 6.860
Authors: V Ozmen; H Karanlik; N Cabioglu; A Igci; M Kecer; O Asoglu; S Tuzlali; A Mudun Journal: Breast Cancer Res Treat Date: 2006-01 Impact factor: 4.872
Authors: Rosa F Hwang; Savitri Krishnamurthy; Kelly K Hunt; Nadeem Mirza; Frederick C Ames; Barry Feig; Henry M Kuerer; S Eva Singletary; Gildy Babiera; Funda Meric; Jeri S Akins; Jessica Neely; Merrick I Ross Journal: Ann Surg Oncol Date: 2003-04 Impact factor: 5.344
Authors: U Veronesi; R Orecchia; S Zurrida; V Galimberti; A Luini; P Veronesi; G Gatti; G D'Aiuto; L Cataliotti; R Paolucci; P Piccolo; N Massaioli; P Sismondi; A Rulli; F Lo Sardo; A Recalcati; D Terribile; A Acerbi; N Rotmensz; P Maisonneuve Journal: Ann Oncol Date: 2005-01-24 Impact factor: 32.976
Authors: C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki Journal: J Clin Oncol Date: 1999-06 Impact factor: 44.544
Authors: Bong Kyun Kim; Byeong-Woo Park; Min Hee Hur; Han-Byoel Lee; Min Ho Park; Joon Jeong; Hyouk Jin Lee; Jina Lee; Dongju Kim; Woo Young Sun Journal: Ann Surg Treat Res Date: 2020-05-28 Impact factor: 1.859